Development of poly(ADP-ribose) polymerase inhibitor and immunotherapy combinations: progress, pitfalls, and promises
10.1016/j.trecan.2021.05.004
Saved in:
Main Authors: | Pham, Melissa M, Ngoi, Natalie YL, Peng, Guang, Tan, David SP, Yap, Timothy A |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
Elsevier BV
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/194100 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Lack of poly(ADP-ribose) polymerase-1 gene product enhances cellular sensitivity to arsenite
by: Poonepalli, A., et al.
Published: (2011) -
Combinatorial-approached neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is there additional benefit?
by: Yap, E., et al.
Published: (2011) -
Role of Poly (ADP-Ribose) Polymerase 1 and Copper Homeostasis Factor, Antioxidant Protein 1 in the Maintenance of Genomic Integrity
by: LAKSHMIDEVI D/O BALAKRISHNAN
Published: (2011) -
Inhibition of poly (ADP-Ribose) polymerase-1 in telomerase deficient mouse embryonic fibroblasts increases arsenite-induced genome instability
by: Gurung, R.L., et al.
Published: (2014) -
Temporal changes in chromatin, intracellular calcium, and poly(ADP-ribose) polymerase during Sindbis virus-induced apoptosis of neuroblastoma cells
by: Sukathida Ubol, et al.
Published: (2018)